سیویلیکا را در شبکه های اجتماعی دنبال نمایید.

Chitosan Nanoparticles: As an Anti-Biofilm Agent against Acinetobacter Strains baumannii Representing the Multidrug Resistance Phenotype

Publish Year: 1402
Type: Journal paper
Language: English
View: 182

This Paper With 14 Page And PDF Format Ready To Download

Export:

Link to this Paper:

Document National Code:

JR_SHIMU-31-2_001

Index date: 18 June 2023

Chitosan Nanoparticles: As an Anti-Biofilm Agent against Acinetobacter Strains baumannii Representing the Multidrug Resistance Phenotype abstract

Introduction: Acinetobacter baumannii (A. baumannii) is a non-fermentative gram-negative coccobacillus that shows high resistance to antimicrobial compounds. Biofilm formation is one of the essential features of many Acinetobacter species that leads to high antibiotic resistance. This study aimed to evaluate the ability of biofilm formation and determine the antibiofilm activity of chitosan nanoparticles in clinical isolates of A. baumannii. Material & Methods: This descriptive cross-sectional study was conducted in 2021 and investigated 100 isolates collected from different hospitals. Microscopic, biochemical, and molecular tests were performed to identify the bacteria. The antibiotic resistance pattern of the isolates was evaluated by the disk diffusion method against 10 antibiotics, and the ability to produce biofilm was evaluated by microtiter plate method. Subsequently, 16SrRNA and CsuA genes were identified by multiplex-PCR molecular methods. After the preparation of chitosan nanoparticles and determination of MIC concentration, antibiofilm activity was measured by plate microtiter, and Real-Time PCR was used to examine the expression of the CsuA gene involved in biofilm. Findings: In this study, out of 100 isolates examined, 29 isolates were confirmed as A. baumannii. Among 29 isolates, ceftazidime had the highest drug resistance (75.86%). The CsuA gene was detected in 51.72% of the isolates. Moreover, using a microtiter plate and Real-Time PCR, the level of antibiotic activity of chitosan nanoparticles was determined at a significant level of P<0.01. Discussion & Conclusion: Considering the anti-biofilm effects found in the present study, it seems that chitosan nanoparticles can be used as a pharmaceutical candidate in the pharmaceutical industry.

Chitosan Nanoparticles: As an Anti-Biofilm Agent against Acinetobacter Strains baumannii Representing the Multidrug Resistance Phenotype Keywords:

Chitosan Nanoparticles: As an Anti-Biofilm Agent against Acinetobacter Strains baumannii Representing the Multidrug Resistance Phenotype authors

غزل قجری

Dept of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran

نگین رجایی

Young Researchers and Elite Club, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran

آرجیت چاکرابورتی

National Sports University, Ministry of Youth Affairs and Sports, Government of India, Imphal

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
Lemiech-Mirowska E, Kiersnowska ZM, Michałkiewicz M, Depta A, Marczak M. ...
Piri Gharaghie T, Sadat Shandiz SA, Beiranvand S. Evaluation of ...
Nocera FP, Attili AR, De Martino L. Acinetobacter baumannii: its ...
Piri Gharaghie T, Sadat Shandiz SA. The inhibitory effects of ...
Bowler P, Murphy C, Wolcott R. Biofilm exacerbates antibiotic resistance: ...
Piri-Gharaghie T, Doosti A, Mirzaei SA. Identification of antigenic properties ...
Pakharukova N, Garnett JA, Tuittila M, Paavilainen S, Diallo M, ...
Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. ...
Piri‐Gharaghie T, Beiranvand S, Riahi A, Shirin NJ, Badmasti F, ...
Piri-Gharaghie T, Doosti A, Mirzaei SA. Fabrication and characterization of ...
Donsì F, Annunziata M, Sessa M, Ferrari G. Nanoencapsulation of ...
Chou SF, Gunaseelan S, Kiellani MH, Thottempudi VV, Neuenschwander P, ...
Van Vuuren SF, du Toit LC, Parry A, Pillay V, ...
Kabiri-Samani S, Sanatgaran M, Shojaei-Barjoei N, Moosavi R, Shaqaqi P, ...
Piri-Gharaghie T, Ghajari G, Hassanpoor M, Jegargoshe-Shirin N, Soosanirad M, ...
Asadipour E, Asgari M, Mousavi P, piri gharaghie T, Ghajari ...
Taghiloo S, Ghajari G, Zand Z, Kabiri-Samani S, Kabiri H, ...
Zarinnezhad A, Shahhoseini MH, Piri Gharaghie T. Evaluating the relative ...
Piri-Gharaghie T, Doosti A, Mirzaei SA. Novel adjuvant nano-vaccine induced ...
Hatami R. The frequency of multidrug-resistance and extensively drug-resistant Acinetobacter ...
Goudarzi H, Douraghi M, Ghalavand Z, Goudarzi M. Assessment of ...
Kooti S, Motamedifar M, Sarvari J. Antibiotic resistance profile and ...
Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter ...
Qi L, Li H, Zhang C, Liang B, Li J, ...
Dadgar T, Vahedi Z, Yazdansetad S, Kiaei E, Asaadi H. ...
Alqahtani F, Aleanizy F, El Tahir E, Alhabib H, Alsaif ...
Gharaghie TP, Beiranvand S, Abbas Doosti AH, Ghadiri SH. A ...
نمایش کامل مراجع